Michael G. Silverman

2 ta ish

Massachusetts General Hospital

1. Dapagliflozin and Cardiovascular Outcomes in Type 2 Diabetes

   Stephen D. Wiviott, Itamar Raz, Marc P. Bonaca +17

   Maqola20183 iqtibos

   ABIABI:AkademIndex/2026.other.282509

2. Association Between Lowering LDL-C and Cardiovascular Risk Reduction Among Different Therapeutic Interventions

   Michael G. Silverman, Brian A. Ference, Kyungah Im +5

   Sharh maqolaOAOchiq kirish20162 iqtibos

   ABIABI:AkademIndex/2026.other.057707